Role of sympathetic nervous system in experimental hypertension and diabetes mellitus

Clinical and Experimental Hypertension

Volumn 21, Issue 1-2, 1999, Pages 95-112

  Kaul, C L ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

6 Hydroxydopamine; Diabetes Mellitus; Sympathetic Nervous System

Indexed keywords

6 HYDROXYDOPA; CREATININE; GLUCOSE; INSULIN; NORADRENALIN; OXPRENOLOL; PHENTOLAMINE; VANILMANDELIC ACID;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; CONFERENCE PAPER; CREATININE URINE LEVEL; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HYPERTENSION; INSULIN RELEASE; MALE; NONHUMAN; NORADRENALIN URINE LEVEL; PATHOPHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RHESUS MONKEY; SYMPATHETIC TONE;

EID: 0033008840     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068653     Document Type: Conference Paper

References (34)

1. Grewal, R.S., Kaul, C.L. Mechanism of the antagonism of the hypotensive effect of guanethidine by propranolol. Br J Pharmac 1970; 38: 771-775.
2. Mark, A.L. The sympathetic nervous system in hypertension: a potential long term regulator of arterial pressure. J Hypertension 1996; 5: 159-165.
3. Dorr, L.D., Brody, M.J. Preliminary observations on the role of sympathetic nervous system in development and maintenance of experimental renal hypertension. Proc Soc Exp Biol Med 1966; 123: 155-158.
4. Willard, P.W., Fuller, R.W. Functional significance of the sympathetic nervous system in the production of hypertension. Nature (Lond) 1969; 233: 417-418.
5. Ayitey-Smith, E., Varma, D.R. An assessment of the role of the sympathetic nervous system in experimental hypertension using normal and immunosympathectomised rats. Br J Pharmac 1970; 40: 175-185.
6. Grewal, R.S., Kaul, C.L. Importance of sympathetic nervous system to the developmentof renal hypertension in the rat. Br J Pharmac 1971; 42: 497-504.
7. Finch, L., Leach, G.D.H. The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat. Br J Pharmac 1970; 39: 317-324.
8. MeCubbin, J.W., Page, I.H. Renal pressor system and neurogenic control of arterial pressure. Circulation Res 1963; 12: 553-559.
9. Koletsky, S., Pritchard W.H. Vasopressor material in experimental renal hypertension. Circulation Res 1963; 13: 552-556.
10. Pritchard W.H., Ormond, A.P. Jun, Koletsky, S. Differences in levels of circulating vasopressor material in dogs with acute and chronic renal hypertension. Proc Soc Exp Biol Med 1964; 117: 127-131.
11. Hano, T., Nishio, J. Hypertension in the patients with impaired glucose tolerance. Nippon Rinsho 1996; 54: 2687-2691.
12. Corry, D.B., Tuck, M.L. Glucose and insulin metabolism in hypertension. Am J Nephrol 1966; 16: 223-236.
13. Thoenen, H., Tranzer, J.P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedeberg's Arch Exp Path Pharmak 1968; 261: 271-288.
14. Goldblatt, H., Lynch, J., Hanzal, R.F., Summerville, W.W. Studies on experimental hypertension. J Exp Med 1934; 59: 347-379.
15. Byrom F., Wilson, C. Plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol (Lond) 1938; 93: 301-304.
16. Crout, J.R., Creveling, C.R, Udenfriend, S. Norepinephrine metabolism in the rat brain and heart. J Pharmac Exp Ther 1961; 132: 269-277.
17. Bertler, A., Carlsson, A., Rosengren, E. A method for the fluorimetric determination of the adrenaline and noradrenaline in tissues. Acta Physiol Scand 1958; 44: 273-292.
18. Pisano, J.J., Crout, J.R., and Abraham, D. Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clinica Chim Acta 1962; 7: 285-291.
19. Folin, O.K.O. Cited in Oscar, Hawk's physiological chemistry; 14th ed. (McGraw-Hill, New York). J Biol Chem 1914; 17: 469.
20. Bourne, G.H., in The Rhesus Monkey, by G.J. Bourne, Academic Press New York (1975) 63.
21. Itaya, K., Ui, M. Colorimetric determination of free fatty acids in biological fluids. J Lipid Res 1965; 6: 16-20.
22. Finch, L., Leach, G.D.H. Does the adrenal medulla contribute to the maintenance of experimental hypertension. Eur J Pharmac 1970; 11: 388-391.
23. Mueller, R.A., Thoenen, H., Axelrod, J.P. Adrenal tyrosine hydroxylase. Compensatory increase in activity after chemical sympathectomy. Science 1969; 163: 468-469.
24. Hamberger, B., Levi, Montalcini, R., Norberg, K.A., Sgoquist, F. Monoamines in immunosympathectomized rats. Int J Neuropharmac 1965; 4: 91-95.
25. Cegrell, L. The occurance of biogenic monoamines in mammalian endocrine pancreas. Acta Physiol Scand Suppl 1968; 314: 60.
26. Christensen, N.J. Plasma catecholamines in long term diabetics with and without neuropathy and in hypophysectomised subjects. J Clin Invest 1972; 51: 779-787.
27. Christensen, N.J. Plasma norepinephrine and epinephrine in untreated diabetic during fasting and after insulin administration. Diabetes 1974; 23: 1-8.
28. Christlieb, A.R. Diabetic and hypertension vascular disease, mechanism and treatment. Am J Cardiol 1973; 32: 592-606.
29. Montanari, R., Custan, E., Beaven, M.A. Brodie, B.B. Turnover rates of norepinephrine in heart of infract mice, rats and guinea pigs using tritiated norepinephrine. Life Sci 1963; 29: 232-240.
30. Harrower, A.D.B. Cardiovascular disease in diabetic mellietus. Br J Clin Pract 1977; 31: 47-51.
31. Kawashima, H., Igarashi, T., Nakajima, Y., Akiyama, Y., Usuki, K., Ohtake, S. Chronic hypertension induced by streptozotocin in rats. Naunyn-Schimedebergs Arch Pharmac 1978; 305: 123-126.
32. Kaul, C.L., Grewal, R.S. Vascular reactivity in streptozotocin induced diabetic rat. Pharm Res Comm 1980; 12: 945-958.
33. Christlieb, A.R. Diabetes and hypertensive vascular disease. Mechanisms and Treatment. Am J Cardiol 1973; 32: 592-606.
34. Clements, R.S. Jr., Morrison, A.D., Weinegard, A.I. Polyol pathway in aorta: regulation by hormones. Science, 1969; 166: 1007-1008.